Amorphous dispersion is a strategy used to improve the solubility and oral bioavailability of poorly water-soluble pharmaceutical compounds. In these systems an amorphous active pharmaceutical ingredient (API) is stabilised by a polymer to produce an arrangement with improved physical and solution stability.
• Increased solubility and bioavailability
• Stabilised amorphous forms
• Controlled particle size distribution